MTOR and acute lymphoblastic leukemia: It has been observed that this fusion contains a poor prognosis of ALL and interacts with several signaling mechanisms (such as RAF/MEK/ERK, STAT5, Akt/mTOR (mammalian target of rapamycin)), which eventually influences apoptosis of lymphoid cells.